Dermavant's Tapinarof Could Bring Innovation To Topical Psoriasis Market

 
• By Jessica Merrill

CEO Todd Zavodnick said the non-steroidal topical cream is poised to become a blockbuster brand.

SC2008_Happy Hand_197966453_1200.jpg
Dermavant hopes to carve out a niche for a new topical psoriasis treatment • Source: Shutterstock

More from Dermatological

More from Therapy Areas